Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jack Roth
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Living Beings
Anatomy
Chemicals & Drugs
Procedures
Genes & Molecular Sequences
Devices
Physiology
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
78
Swisher, Stephen
54
Walsh, Garrett
52
Putnam, Joe
45
Komaki, Ritsuko
45
Vaporciyan, Ara
40
Fang, Bingliang
35
Correa, Arlene
27
Ji, Lin
27
Rice, David
23
Ajani, Jaffer
21
Hong, Waun Ki
19
Hofstetter, Wayne
19
Chada, Sunil
19
Smythe, Roy
18
Cristiano, Richard
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jack Roth (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Bolton William D; Hofstetter Wayne L; Francis Ashleigh M; Correa Arlene M; Ajani Jaffer A; Bhutani Manoop S; Erasmus Jeremy; Komaki Ritsuko; Maru Dipen M; Mehran Reza J; Rice David C; Roth Jack A; Vaporciyan Ara A; Walsh Garrett L; Swisher Stephen G
Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma.
The Journal of thoracic and cardiovascular surgery 2009;138(4):831-6.
-
2009: Braiteh Fadi; Correa Arlene M; Hofstetter Wayne L; Rice David C; Vaporciyan Ara A; Walsh Garrett L; Roth Jack A; Mehran Reza J; Swisher Stephen G; Ajani Jaffer A
Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy.
Cancer 2009;115(19):4450-8.
-
2009: Blackmon Shanda H; Shah Nipam; Roth Jack A; Correa Arlene M; Vaporciyan Ara A; Rice David C; Hofstetter Wayne; Walsh Garrett L; Benjamin Robert; Pollock Raphael; Swisher Stephen G; Mehran Reza
Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival.
The Annals of thoracic surgery 2009;88(3):877-84; discussion 884-5.
-
2009: William William N; Lin Heather Y; Lee J Jack; Lippman Scott M; Roth Jack A; Kim Edward S
Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data.
Chest 2009;136(3):701-9.
-
2009: Du Liqin; Schageman Jeoffrey J; Subauste Maria C; Saber Barbara; Hammond Scott M; Prudkin Ludmila; Wistuba Ignacio I; Ji Lin; Roth Jack A; Minna John D; Pertsemlidis Alexander
miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1.
Molecular cancer research : MCR 2009;7(8):1234-43.
-
2009: Kassis Edmund S; Vaporciyan Ara A; Swisher Stephen G; Correa Arlene M; Bekele B Nebiyou; Erasmus Jeremy J; Hofstetter Wayne L; Komaki Ritsuko; Mehran Reza J; Moran Cesar A; Pisters Katherine M; Rice David C; Walsh Garrett L; Roth Jack A
Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population.
The Journal of thoracic and cardiovascular surgery 2009;138(2):412-418.e1-2.
-
2009: Bolton William D; Rice David C; Goodyear Adam; Correa Arlene M; Erasmus Jeremy; Hofstetter Wayne; Komaki Ritsuko; Mehran Reza; Pisters Katherine; Roth Jack A; Swisher Stephen G; Vaporciyan Ara A; Walsh Garrett L; Weaver Jason; Rhines Laurence
Superior sulcus tumors with vertebral body involvement: a multimodality approach.
The Journal of thoracic and cardiovascular surgery 2009;137(6):1379-87.
-
2009: Tsao Anne S; Wistuba Ignacio; Roth Jack A; Kindler Hedy Lee
Malignant pleural mesothelioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(12):2081-90.
-
2009: Yendamuri Sai; Swisher Stephen G; Correa Arlene M; Hofstetter Wayne; Ajani Jaffer A; Francis Ashleigh; Maru Dipen; Mehran Reza J; Rice David C; Roth Jack A; Walsh Garrett L; Vaporciyan Ara A
Esophageal tumor length is independently associated with long-term survival.
Cancer 2009;115(3):508-16.
-
2009: Tsao Anne S; Mehran Reza; Roth Jack A
Neoadjuvant and intrapleural therapies for malignant pleural mesothelioma.
Clinical lung cancer 2009;10(1):36-41.
-
2008: Chang Joe Y; Balter Peter A; Dong Lei; Yang Qiuan; Liao Zhongxing; Jeter Melenda; Bucci M Kara; McAleer Mary F; Mehran Reza J; Roth Jack A; Komaki Ritsuko
Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2008;72(4):967-71.
-
2008: Pataer Abujiang; Hu Wenxian; Xiaolin Lu; Chada Sunil; Roth Jack A; Hunt Kelly K; Swisher Stephen G
Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing.
Molecular cancer therapeutics 2008;7(8):2528-35.
-
2008: Katz Ruth L; Zaidi Tanweer M; Fernandez Ricardo L; Zhang Jingpin; He Weigong; Acosta Charisse; Daniely Michal; Madi Lea; Vargas Mary A; Dong Qiong; Gao Xiaoying; Jiang Feng; Caraway Nancy P; Vaporciyan Ara A; Roth Jack A; Spitz Margaret R
Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(8):950-60.
-
2008: Roth Jack A
Gene therapy in thoracic oncology.
The Annals of thoracic surgery 2008;85(5):1837-8.
-
2008: Ji Lin; Roth Jack A
Tumor suppressor FUS1 signaling pathway.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(4):327-30.
-
2008: Prudkin Ludmila; Behrens Carmen; Liu Diane D; Zhou Xian; Ozburn Natalie C; Bekele B Nebiyou; Minna John D; Moran Cesar; Roth Jack A; Ji Lin; Wistuba Ignacio I
Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(1):41-7.
-
2008: Pataer Abujiang; Chada Sunil; Roth Jack A; Hunt Kelly K; Swisher Stephen G
Development of Ad-mda7/IL-24-resistant lung cancer cell lines.
Cancer biology & therapy 2008;7(1):103-8.
-
2008: Deng W-G; Wu G; Ueda K; Xu K; Roth J A; Ji L
Enhancement of antitumor activity of cisplatin in human lung cancer cells by tumor suppressor FUS1.
Cancer gene therapy 2008;15(1):29-39.
-
2008: Deus Helena F; Stanislaus Romesh; Veiga Diogo F; Behrens Carmen; Wistuba Ignacio I; Minna John D; Garner Harold R; Swisher Stephen G; Roth Jack A; Correa Arlene M; Broom Bradley; Coombes Kevin; Chang Allen; Vogel Lynn H; Almeida Jonas S
A Semantic Web management model for integrative biomedical informatics.
PloS one 2008;3(8):e2946.
-
2008: Chada Sunil; Menander Kerstin B; Bocangel Dora; Roth Jack A; Ramesh Rajagopal
Cancer targeting using tumor suppressor genes.
Frontiers in bioscience : a journal and virtual library 2008;13():1959-67.
-
2007: Yendamuri Sai; Komaki Ritsuko R; Correa Arlene M; Allen Pamela; Wynn Bob; Blackmon Shanda; Hofstetter Wayne L; Rice David C; Roth Jack A; Swisher Stephen G; Vaporciyan Ara A; Walsh Garrett L; Mehran Reza J
Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(11):1022-8.
-
2007: Jayachandran Gitanjali; Sazaki Ji-ichiro; Nishizaki Masahito; Xu Kai; Girard Luc; Minna John D; Roth Jack A; Ji Lin
Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch.
Cancer research 2007;67(21):10379-88.
-
2007: Hittelman Walter N; Liu Diane D; Kurie Jonathan M; Lotan Reuben; Lee Jin Soo; Khuri Fadlo; Ibarguen Heladio; Morice Rodolfo C; Walsh Garrett; Roth Jack A; Minna John; Ro Jae Y; Broxson Anita; Hong Waun Ki; Lee J Jack
Proliferative changes in the bronchial epithelium of former smokers treated with retinoids.
Journal of the National Cancer Institute 2007;99(21):1603-12.
-
2007: Rice David C; Stevens Craig W; Correa Arlene M; Vaporciyan Ara A; Tsao Anne; Forster Kenneth M; Walsh Garrett L; Swisher Stephen G; Hofstetter Wayne L; Mehran Reza J; Roth Jack A; Liao Zhongxing; Smythe W Roy
Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.
The Annals of thoracic surgery 2007;84(5):1685-92; discussion 1692-3.
-
2007: von Holzen Urs; Pataer Abujiang; Raju Uma; Bocangel Dora; Vorburger Stephan A; Liu Yanna; Lu Xiaolin; Roth Jack A; Aggarwal Bharat B; Barber Glen N; Keyomarsi Khandan; Hunt Kelly K; Swisher Stephen G
The double-stranded RNA-activated protein kinase mediates radiation resistance in mouse embryo fibroblasts through nuclear factor kappaB and Akt activation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6032-9.
-
2007: Roth Jack A
Treatment of esophageal cancer: does surgery make the cut?
Gastrointestinal cancer research : GCR 2007;1(5):207-8.
-
2007: Bakaeen Faisal; Rice David; Correa Arlene M; Walsh Garrett L; Vaporciyan Ara A; Putnam Joe B; Swisher Stephen G; Roth Jack A; Huh Joe; Chu Danny; Smythe W Roy
Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications.
The Annals of thoracic surgery 2007;84(3):982-6.
-
2007: Martin Linda W; Correa Arlene M; Ordonez Nelson G; Roth Jack A; Swisher Stephen G; Vaporciyan Ara A; Walsh Garrett L; Rice David C
Sarcomatoid carcinoma of the lung: a predictor of poor prognosis.
The Annals of thoracic surgery 2007;84(3):973-80.
-
2007: Deng Wu-Guo; Jayachandran Gitanjali; Wu Guanglin; Xu Kai; Roth Jack A; Ji Lin
Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
The Journal of biological chemistry 2007;282(36):26460-70.
-
2007: Hofstetter Wayne; Correa Arlene M; Bekele Neby; Ajani Jaffer A; Phan Alexandria; Komaki Ritsuko R; Liao Zhongxing; Maru Dipen; Wu Tsung T; Mehran Reza J; Rice David C; Roth Jack A; Vaporciyan Ara A; Walsh Garrett L; Francis Ashleigh; Blackmon Shanda; Swisher Stephen G
Proposed modification of nodal status in AJCC esophageal cancer staging system.
The Annals of thoracic surgery 2007;84(2):365-73; discussion 374-5.
-
2007: Ohtani Shoichiro; Iwamaru Arifumi; Deng Wuguo; Ueda Kentaro; Wu Guanglin; Jayachandran Gitanjali; Kondo Seiji; Atkinson Edward N; Minna John D; Roth Jack A; Ji Lin
Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy.
Cancer research 2007;67(13):6293-303.
-
2007: Chang Joe Y; Roth Jack A
Stereotactic body radiation therapy for stage I non-small cell lung cancer.
Thoracic surgery clinics 2007;17(2):251-9.
-
2007: Blackmon Shanda H; Correa Arlene M; Wynn Bob; Hofstetter Wayne L; Martin Linda W; Mehran Reza J; Rice David C; Swisher Steven G; Walsh Garrett L; Roth Jack A; Vaporciyan Ara A
Propensity-matched analysis of three techniques for intrathoracic esophagogastric anastomosis.
The Annals of thoracic surgery 2007;83(5):1805-13; discussion 1813.
-
2007: Deng Wu-Guo; Nishizaki Masahiko; Fang Bingliang; Roth Jack A; Ji Lin
Induction of apoptosis by tumor suppressor FHIT via death receptor signaling pathway in human lung cancer cells.
Biochemical and biophysical research communications 2007;355(4):993-9.
-
2007: Deng Wu-Guo; Kawashima Hiroyaki; Wu Guanglin; Jayachandran Gitanjali; Xu Kai; Minna John D; Roth Jack A; Ji Lin
Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells.
Cancer research 2007;67(2):709-17.
-
2007: Pataer A; Bocangel D; Chada S; Roth J A; Hunt K K; Swisher S G
Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue.
Cancer gene therapy 2007;14(1):12-8.
-
2006: Gu Jian; Berman David; Lu Charles; Wistuba Ignacio I; Roth Jack A; Frazier Marsha; Spitz Margaret R; Wu Xifeng
Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7329-38.
-
2006: Herrera Luis J; Correa Arlene M; Vaporciyan Ara A; Hofstetter Wayne L; Rice David C; Swisher Stephen G; Walsh Garrett L; Roth Jack A; Mehran Reza J
Increased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients.
The Annals of thoracic surgery 2006;82(6):1982-7; discussion 1987-8.
-
2006: Ueda Kentaro; Kawashima Hiroyuki; Ohtani Shoichiro; Deng Wu-Guo; Ravoori Murali; Bankson Jim; Gao Boning; Girard Luc; Minna John D; Roth Jack A; Kundra Vikas; Ji Lin
The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells.
Cancer research 2006;66(19):9682-90.
-
2006: Malaisrie S Chris; Hofstetter Wayne L; Correa Arlene M; Ajani Jaffer A; Komaki Ritsuko R; Rice David C; Vaporciyan Ara A; Walsh Garrett L; Roth Jack A; Wu Tsung T; Swisher Stephen G
The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma.
Cancer 2006;107(5):967-74.
-
2006: Pataer A; Fanale M A; Roth J A; Swisher S G; Hunt K K
Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53.
Cancer gene therapy 2006;13(8):806-14.
-
2006: Peng Henry H; Wu Shuhong; Davis John J; Wang Li; Roth Jack A; Marini Frank C; Fang Bingliang
A rapid and efficient method for purification of recombinant adenovirus with arginine-glycine-aspartic acid-modified fibers.
Analytical biochemistry 2006;354(1):140-7.
-
2006: Liao Zhongxing; Liu Hongji; Swisher Stephen G; Wang Luo; Wu Tsung-Teh; Correa Arlene M; Roth Jack A; Cox James D; Komaki Ritsuko; Ajani Jaffer A; Wei Qingyi
Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation.
International journal of radiation oncology, biology, physics 2006;64(3):700-8.
-
2006: Rohatgi Pooja R; Swisher Stephen G; Correa Arlene M; Wu Tsung T; Liao Zhongxing; Komaki Ritsuko; Walsh Garrett L; Vaporciyan Ara A; Rice David C; Bresalier Robert S; Roth Jack A; Ajani Jaffer A
Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy.
Cancer 2006;106(3):552-8.
-
2006: Malaisrie S Chris; Hofstetter Wayne L; Correa Arlene M; Ajani Jaffer A; Komaki Ritsuko R; Liao Zhongxing; Phan Alexandria; Rice David C; Vaporciyan Ara A; Walsh Garrett L; Lahoti Sandeep; Lee Jeffrey H; Bresalier Robert; Roth Jack A; Swisher Stephen G
Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma.
The Journal of thoracic and cardiovascular surgery 2006;131(1):65-72.
-
2006: Roth Jack A
Adenovirus p53 gene therapy.
Expert opinion on biological therapy 2006;6(1):55-61.
-
2006: Guo W; Zhu H; Zhang L; Davis J; Teraishi F; Roth J A; Stephens C; Fueyo J; Jiang H; Conrad C; Fang B
Combination effect of oncolytic adenovirotherapy and TRAIL gene therapy in syngeneic murine breast cancer models.
Cancer gene therapy 2006;13(1):82-90.
-
2006: Martin Linda W; Hofstetter Wayne; Swisher Stephen G; Roth Jack A
Management of intrathoracic leaks following esophagectomy.
Advances in surgery 2006;40():173-90.
-
2006: Rohatgi P R; Correa A M; Swisher S G; Wu T T; Liao Z; Komaki R; Walsh G L; Vaporciyan A A; Lee J H; Rice D C; Roth J A; Ajani J A
Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2006;19(3):152-7.
-
2005: Martin Linda W; Correa Arlene M; Hofstetter Wayne; Hong Waun Ki; Komaki Ritsuko; Putnam Joe B; Rice David C; Smythe W Roy; Swisher Stephen G; Vaporciyan Ara A; Walsh Garrett L; Roth Jack A
The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
The Journal of thoracic and cardiovascular surgery 2005;130(6):1601-10.
-
2005: Rohatgi Pooja; Swisher Stephen G; Correa Arlene M; Wu Tsung-T; Liao Zhongxing; Komaki Ritsuko; Walsh Garrett L; Vaporciyan Ara A; Rice David C; Roth Jack A; Ajani Jaffer A
Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response.
Cancer 2005;104(11):2365-72.
-
2005: Hamada Katsuyuki; Sakaue Morito; Sarkar Asis; Buchl Stepanie; Satterfield William; Keeling Michale; Sastry Jagannandha; Roth Jack A; Follen Michele
Immune responses to repetitive adenovirus-mediated gene transfer and restoration of gene expression by cyclophosphamide or etoposide.
Gynecologic oncology 2005;99(3 Suppl 1):S177-86.
-
2005: Hamada Katsuyuki; Ueda Norifumi; Ito Masaharu; Roth Jack A; Follen Michele
The nude rat as an orthotopic model for cervical cancer.
Gynecologic oncology 2005;99(3 Suppl 1):S159-65.
-
2005: Ascioti Anthony J; Hofstetter Wayne L; Miller Michael J; Rice David C; Swisher Stephen G; Vaporciyan Ara A; Roth Jack A; Putnam J B; Smythe W Roy; Feig Barry W; Mansfield Paul F; Pisters Peter W T; Torres Marla T; Walsh Garrett L
Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction.
The Journal of thoracic and cardiovascular surgery 2005;130(5):1391-8.
-
2005: Rohatgi Pooja R; Swisher Stephen G; Correa Arlene M; Wu Tsung T; Liao Zhongxing; Komaki Ritsuko; Walsh Garrett; Vaporciyan Ara; Lynch Patrick M; Rice David C; Roth Jack A; Ajani Jaffer A
Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus.
Cancer 2005;104(7):1349-55.
-
2005: Tang Ximing; Shigematsu Hisayuki; Bekele B Nebiyou; Roth Jack A; Minna John D; Hong Waun Ki; Gazdar Adi F; Wistuba Ignacio I
EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.
Cancer research 2005;65(17):7568-72.
-
2005: Martin Linda W; Swisher Stephen G; Hofstetter Wayne; Correa Arlene M; Mehran Reza J; Rice David C; Vaporciyan Ara A; Walsh Garrett L; Roth Jack A
Intrathoracic leaks following esophagectomy are no longer associated with increased mortality.
Annals of surgery 2005;242(3):392-9; discussion 399-402.
-
2005: Agarwal Banke; Swisher Stephen G; Ajani Jaffer; Kelly Kaitlyn; Komaki Ritsuko R; Abu-Hamda Emad; Correa Arlene M; Roth Jack A
Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
The Annals of thoracic surgery 2005;79(5):1716-23.
-
2005: Pataer Abujiang; Vorburger Stephan A; Chada Sunil; Balachandran Siddharth; Barber Glen N; Roth Jack A; Hunt Kelly K; Swisher Stephen G
Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;11(5):717-23.
-
2005: Swisher Stephen G; Hofstetter Wayne; Wu Tsung T; Correa Arlene M; Ajani Jaffer A; Komaki Ritsuko R; Chirieac Lucian; Hunt Kelly K; Liao Zhongxing; Phan Alexandria; Rice David C; Vaporciyan Ara A; Walsh Garrett L; Roth Jack A
Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT).
Annals of surgery 2005;241(5):810-7; discussion 817-20.
-
2005: Chirieac Lucian R; Swisher Stephen G; Ajani Jaffer A; Komaki Ritsuko R; Correa Arlene M; Morris Jeffrey S; Roth Jack A; Rashid Asif; Hamilton Stanley R; Wu Tsung-Teh
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation.
Cancer 2005;103(7):1347-55.
-
2005: Saito Yuji; Miyahara Ryo; Gopalan Began; Litvak Anya; Inoue Satoshi; Shanker Manish; Branch Cynthia D; Mhashilkar Abner M; Roth Jack A; Chada Sunil; Ramesh Rajagopal
Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interleukin-24 (IL-24) gene.
Cancer gene therapy 2005;12(3):238-47.
-
2005: Ji Lin; Minna John D; Roth Jack A
3p21.3 tumor suppressor cluster: prospects for translational applications.
Future oncology (London, England) 2005;1(1):79-92.
-
2005: Sasaki Ryohei; Komaki Ritsuko; Macapinlac Homer; Erasmus Jeremy; Allen Pamela; Forster Kenneth; Putnam Joe B; Herbst Roy S; Moran Cesar A; Podoloff Donald A; Roth Jack A; Cox James D
[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(6):1136-43.
-
2005: Oida Yasuhisa; Gopalan Began; Miyahara Ryo; Inoue Satoshi; Branch Cynthia D; Mhashilkar Abner M; Lin E; Bekele B Nebiyou; Roth Jack A; Chada Sunil; Ramesh Rajagopal
Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer.
Molecular cancer therapeutics 2005;4(2):291-304.
-
2005: Rice David C; Correa Arlene M; Vaporciyan Ara A; Sodhi Nidhi; Smythe W Roy; Swisher Stephen G; Walsh Garrett L; Putnam Joe B; Komaki Ritsuko; Ajani Jaffer A; Roth Jack A
Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.
The Annals of thoracic surgery 2005;79(2):391-7; discussionn 391-7.
-
2005: Wu Xifeng; Roth Jack A; Zhao Hua; Luo Sherry; Zheng Yun-Ling; Chiang Silvia; Spitz Margaret R
Cell cycle checkpoints, DNA damage/repair, and lung cancer risk.
Cancer research 2005;65(1):349-57.
-
2005: Rohatgi Pooja R; Swisher Stephen G; Correa Arlene M; Wu Tsung-T; Liao Zhongxing; Walsh Garrett L; Vaporciyan Ara A; Rice David C; Fukami Norio; Roth Jack A; Ajani Jaffer A
Comparison of clinical stage, therapy response, and patient outcome between squamous cell carcinoma and adenocarcinoma of the esophagus.
International journal of gastrointestinal cancer 2005;36(2):69-76.
-
2004: Ramesh Rajagopal; Ito Isao; Saito Yuji; Wu Zheng; Mhashikar Abner M; Wilson Deborah R; Branch Cynthia D; Roth Jack A; Chada Sunil
Local and systemic inhibition of lung tumor growth after nanoparticle-mediated mda-7/IL-24 gene delivery.
DNA and cell biology 2004;23(12):850-7.
-
2004: Liao Zhongxing; Zhang Zhen; Jin Jing; Ajani Jaffer A; Swisher Stephen G; Stevens Craig W; Ho Linus; Smythe Roy; Vaporciyan Ara A; Putnam Joe B; Walsh Garrett L; Roth Jack A; Yao James C; Allen Pamela K; Cox James D; Komaki Ritsuko
Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
International journal of radiation oncology, biology, physics 2004;60(5):1484-93.
-
2004: Gopalan Began; Ito Isao; Branch Cynthia D; Stephens Clifton; Roth Jack A; Ramesh Rajagopal
Nanoparticle based systemic gene therapy for lung cancer: molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response.
Technology in cancer research & treatment 2004;3(6):647-57.
-
2004: Ito Isao; Ji Lin; Tanaka Fumihiro; Saito Yuji; Gopalan Began; Branch Cynthia D; Xu Kai; Atkinson E Neely; Bekele Benjamin N; Stephens L Clifton; Minna John D; Roth Jack A; Ramesh Rajagopal
Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo.
Cancer gene therapy 2004;11(11):733-9.
-
2004: Swisher Stephen G; Maish Mary; Erasmus Jeremy J; Correa Arlene M; Ajani Jaffer A; Bresalier Robert; Komaki Ritsuko; Macapinlac Homer; Munden Reginald F; Putnam Joe B; Rice David; Smythe W Roy; Vaporciyan Ara A; Walsh Garrett L; Wu Tsung T; Roth Jack A
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
The Annals of thoracic surgery 2004;78(4):1152-60; discussion 1152-60.
-
2004: Swisher Stephen G; Erasmus Jeremy; Maish Mary; Correa Arlene M; Macapinlac Homer; Ajani Jaffer A; Cox James D; Komaki Ritsuko R; Hong David; Lee Hoon K; Putnam Joe B; Rice David C; Smythe W Roy; Thai Linh; Vaporciyan Ara A; Walsh Garrett L; Wu Tsung-Teh; Roth Jack A
2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
Cancer 2004;101(8):1776-85.
-
2004: Gomyo Yoshihito; Sasaki Ji-ichiro; Branch Cynthia; Roth Jack A; Mukhopadhyay Tapas
5-aza-2'-deoxycytidine upregulates caspase-9 expression cooperating with p53-induced apoptosis in human lung cancer cells.
Oncogene 2004;23(40):6779-87.
-
2004: Nishizaki Masahiko; Sasaki Ji-Ichiro; Fang Bingliang; Atkinson Edward N; Minna John D; Roth Jack A; Ji Lin
Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells.
Cancer research 2004;64(16):5745-52.
-
2004: Agarwal Banke; Swisher Stephen; Ajani Jaffer; Kelly Kaitlyn; Fanning Christina; Komaki Ritsuko R; Putnam Joe B; Abu-Hamda Emad; Molke Kimber L; Walsh Garrett L; Correa Arlene M; Ho Linus; Liao Zhongxing; Lynch Patrick M; Rice David C; Smythe W Roy; Stevens Craig W; Vaporciyan Ara A; Yao James; Roth Jack A
Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection.
The American journal of gastroenterology 2004;99(7):1258-66.
-
2004: Ajani Jaffer A; Walsh Garrett; Komaki Ritsuko; Morris Jeff; Swisher Stephen G; Putnam Joe B; Lynch Patrick M; Wu Tsung-Teh; Smythe Roy; Vaporciyan Ara; Faust Josephine; Cohen Deborah S; Nivers Rebecca; Roth Jack A
Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction.
Cancer 2004;100(11):2347-54.
-
2004: Uno Futoshi; Sasaki Jiichiro; Nishizaki Masahiko; Carboni Giovanni; Xu Kai; Atkinson Edward N; Kondo Masashi; Minna John D; Roth Jack A; Ji Lin
Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells.
Cancer research 2004;64(9):2969-76.
-
2004: Chada Sunil; Sutton R Bryan; Ekmekcioglu Suhendan; Ellerhorst Julie; Mumm John B; Leitner Wolfgang W; Yang Heng-Yin; Sahin Aysegul A; Hunt Kelly K; Fuson Kerry L; Poìndexter Nancy; Roth Jack A; Ramesh Rajagopal; Grimm Elizabeth A; Mhashilkar Abner M
MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.
International immunopharmacology 2004;4(5):649-67.
-
2004: Tsunemitsu Y; Kagawa S; Tokunaga N; Otani S; Umeoka T; Roth J A; Fang B; Tanaka N; Fujiwara T
Molecular therapy for peritoneal dissemination of xenotransplanted human MKN-45 gastric cancer cells with adenovirus mediated Bax gene transfer.
Gut 2004;53(4):554-60.
-
2004: Honda Tsuyoshi; Coppola Simona; Ghibelli Lina; Cho Song H; Kagawa Shunsuke; Spurgers Kevin B; Brisbay Shawn M; Roth Jack A; Meyn Raymond E; Fang Bingliang; McDonnell Timothy J
GSH depletion enhances adenoviral bax-induced apoptosis in lung cancer cells.
Cancer gene therapy 2004;11(4):249-55.
-
2004: Ito Isao; Saeki Tomoyuki; Mohuiddin Imran; Saito Yuji; Branch Cynthia D; Vaporciyan Ara; Roth Jack A; Ramesh Rajagopal
Persistent transgene expression following intravenous administration of a liposomal complex: role of interleukin-10-mediated immune suppression.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;9(3):318-27.
-
2004: Vaporciyan Ara A; Correa Arlene M; Rice David C; Roth Jack A; Smythe W R; Swisher Stephen G; Walsh Garrett L; Putnam Joe B
Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients.
The Journal of thoracic and cardiovascular surgery 2004;127(3):779-86.
-
2004: Roth Jack A; Grammer Susan F
Gene replacement therapy for non-small cell lung cancer: a review.
Hematology/oncology clinics of North America 2004;18(1):215-29.
-
2004: Gu Jian; Zhang Lidong; Swisher Stephen G; Liu Jinsong; Roth Jack A; Fang Bingliang
Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis.
Oncogene 2004;23(6):1300-7.
-
2004: Ohtani Shoichiro; Kagawa Shunsuke; Tango Yasuhisa; Umeoka Tatsuo; Tokunaga Naoyuki; Tsunemitsu Yousuke; Roth Jack A; Taya Yoichi; Tanaka Noriaki; Fujiwara Toshiyoshi
Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo.
Molecular cancer therapeutics 2004;3(1):93-100.
-
2004: Yang Q; Cleary K R; Yao J C; Swisher S G; Roth J A; Lynch P M; Komaki R; Ajani J A; Rashid A; Hamilton S R; Wu T-T
Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2004;17(1):38-43.
-
2003: Lee Hoon K; Vaporciyan Ara A; Cox James D; Tucker Susan L; Putnam Joe B; Ajani Jaffer A; Liao Zhongxing; Swisher Stephen G; Roth Jack A; Smythe W Roy; Walsh Garrett L; Mohan Radhe; Liu Hui H; Mooring Deidre; Komaki Ritsuko
Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters.
International journal of radiation oncology, biology, physics 2003;57(5):1317-22.
-
2003: Sah Nand K; Munshi Anupama; Nishikawa Takashi; Mukhopadhyay Tapas; Roth Jack A; Meyn Raymond E
Adenovirus-mediated wild-type p53 radiosensitizes human tumor cells by suppressing DNA repair capacity.
Molecular cancer therapeutics 2003;2(11):1223-31.
-
2003: Saito Yuji; Gopalan Began; Mhashilkar Abner M; Roth Jack A; Chada Sunil; Zumstein Louis; Ramesh Rajagopal
Adenovirus-mediated PTEN treatment combined with caffeine produces a synergistic therapeutic effect in colorectal cancer cells.
Cancer gene therapy 2003;10(11):803-13.
-
2003: Fang Bingliang; Roth Jack A
The role of gene therapy in combined modality treatment strategies for cancer.
Current opinion in molecular therapeutics 2003;5(5):475-82.
-
2003: Lin Tongyu; Zhang Lidong; Davis John; Gu Jian; Nishizaki Masahiko; Ji Lin; Roth Jack A; Xiong Momiao; Fang Bingliang
Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(3):441-8.
-
2003: Swisher Stephen G; Ajani Jaffer A; Komaki Ritsuko; Nesbitt Jonathan C; Correa Arlene M; Cox James D; Lahoti Sandeep; Martin Faye; Putnam Joe B; Smythe W Roy; Vaporciyan Ara A; Walsh Garrett L; Roth Jack A
Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer.
International journal of radiation oncology, biology, physics 2003;57(1):120-7.
-
2003: Mhashilkar Abner M; Stewart Alexis L; Sieger Kerry; Yang Heng-Yin; Khimani Anis H; Ito Isao; Saito Yuji; Hunt Kelly K; Grimm Elizabeth A; Roth Jack A; Meyn Raymond E; Ramesh Rajagopal; Chada Sunil
MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(2):207-19.
-
2003: Fang Bingliang; Roth Jack A
Tumor-suppressing gene therapy.
Cancer biology & therapy 2003;2(4 Suppl 1):S115-21.
-
2003: Pataer Abujiang; Chada Sunil; Hunt Kelly K; Roth Jack A; Swisher Stephen G
Adenoviral melanoma differentiation-associated gene 7 induces apoptosis in lung cancer cells through mitochondrial permeability transition-independent cytochrome c release.
The Journal of thoracic and cardiovascular surgery 2003;125(6):1328-35.
-
2003: Huang Xuefeng; Lin Tongyu; Gu Jian; Zhang Lidong; Roth Jack A; Liu Jinsong; Fang Bingliang
Cell to cell contact required for bystander effect of the TNF-related apoptosis-inducing ligand (TRAIL) gene.
International journal of oncology 2003;22(6):1241-5.
-
2003: Ito Isao; Began Gopalan; Mohiuddin Imran; Saeki Tomoyuki; Saito Yuji; Branch Cynthia D; Vaporciyan Ara; Stephens L Clifton; Yen Nancy; Roth Jack A; Ramesh Rajagopal
Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(3):409-18.
-
2003: Milas Ivan; Komaki Ritsuko; Hachiya Tsutomu; Bubb Robbin S; Ro Jae Y; Langford Lauren; Sawaya Raymond; Putnam Joe B; Allen Pamela; Cox James D; McDonnell Timothy J; Brock William; Hong Waun Ki; Roth Jack A; Milas Luka
Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):1070-6.
-
2003: Kurie Jonathan M; Lotan Reuben; Lee J Jack; Lee Jin Soo; Morice Rodolfo C; Liu Diane D; Xu Xiao-Chun; Khuri Fadlo R; Ro Jae Y; Hittelman Walter N; Walsh Garrett L; Roth Jack A; Minna John D; Hong Waun Ki
Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial.
Journal of the National Cancer Institute 2003;95(3):206-14.
-
2003: Carboni Giovanni L; Gao Boning; Nishizaki Masahiko; Xu Kai; Minna John D; Roth Jack A; Ji Lin
CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity.
Oncogene 2003;22(4):615-26.
-
2003: Roth Jack A; Grammer Susan F
Tumor suppressor gene therapy.
Methods in molecular biology (Clifton, N.J.) 2003;223():577-98.
-
2002: Sasaki Ji-ichiro; Ramesh Rajagopal; Chada Sunil; Gomyo Yoshihito; Roth Jack A; Mukhopadhyay Tapas
The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells.
Molecular cancer therapeutics 2002;1(13):1201-9.
-
2002: Lin Tongyu; Huang Xuefeng; Gu Jian; Zhang Lidong; Roth Jack A; Xiong Momiao; Curley Steven A; Yu Yinhua; Hunt Kelly K; Fang Bingliang
Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.
Oncogene 2002;21(52):8020-8.
-
2002: Kawabe Shinichiro; Nishikawa Takashi; Munshi Anupama; Roth Jack A; Chada Sunil; Meyn Raymond E
Adenovirus-mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(5):637-44.
-
2002: Huang X; Lin T; Gu J; Zhang L; Roth J A; Stephens L C; Yu Y; Liu J; Fang B
Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft.
Gene therapy 2002;9(20):1379-86.
-
2002: Mukhopadhyay Tapas; Sasaki Ji-ichiro; Ramesh Rajagopal; Roth Jack A
Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):2963-9.
-
2002: Zhang L; Gu J; Lin T; Huang X; Roth J A; Fang B
Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.
Gene therapy 2002;9(18):1262-70.
-
2002: Hofstetter Wayne; Swisher Stephen G; Correa Arlene M; Hess Kenneth; Putnam Joe B; Ajani Jaffer A; Dolormente Marcelo; Francisco Rhodette; Komaki Ritsuko R; Lara Axbal; Martin Faye; Rice David C; Sarabia Arcenio J; Smythe W Roy; Vaporciyan Ara A; Walsh Garrett L; Roth Jack A
Treatment outcomes of resected esophageal cancer.
Annals of surgery 2002;236(3):376-84; discussion 384-5.
-
2002: Stewart Alexis L; Mhashilkar Abner M; Yang Xiaohong Helena; Ekmekcioglu Suhendan; Saito Yuji; Sieger Kerry; Schrock Robert; Onishi Eric; Swanson Xin; Mumm John B; Zumstein Lou; Watson Graham J; Snary David; Roth Jack A; Grimm Elizabeth A; Ramesh Rajagopal; Chada Sunil
PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cells.
Molecular medicine (Cambridge, Mass.) 2002;8(8):451-61.
-
2002: Bubb Robbin S; Komaki Ritsuko; Hachiya Tsutomu; Milas Ivan; Ro Jae Y; Langford Lauren; Sawaya Raymond; Putnam Joe B; Allen Pamela; Cox James D; McDonnell Timothy J; Brock William; Hong Waun K; Roth Jack A; Milas Luka
Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion.
International journal of radiation oncology, biology, physics 2002;53(5):1216-24.
-
2002: Swisher Stephen G; Roth Jack A
Clinical update of Ad-p53 gene therapy for lung cancer.
Surgical oncology clinics of North America 2002;11(3):521-35.
-
2002: Tango Yasuhisa; Fujiwara Toshiyoshi; Itoshima Takahiro; Takata Yoshiko; Katsuda Kou; Uno Futoshi; Ohtani Shoichiro; Tani Tohru; Roth Jack A; Tanaka Noriaki
Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells.
Human gene therapy 2002;13(11):1373-82.
-
2002: Gu Jian; Zhang Lidong; Huang Xuefeng; Lin Tongyu; Yin Min; Xu Kai; Ji Lin; Roth Jack A; Fang Bingliang
A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo.
Oncogene 2002;21(31):4757-64.
-
2002: Saeki Tomoyuki; Mhashilkar Abner; Swanson Xin; Zou-Yang X Helena; Sieger Kerry; Kawabe Shinichiro; Branch Cynthia D; Zumstein Louis; Meyn Raymond E; Roth Jack A; Chada Sunil; Ramesh Rajagopal
Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo.
Oncogene 2002;21(29):4558-66.
-
2002: Swisher Stephen G; Roth Jack A
p53 Gene therapy for lung cancer.
Current oncology reports 2002;4(4):334-40.
-
2002: Nutt Leta K; Chandra Joya; Pataer Abujiang; Fang Bingliang; Roth Jack A; Swisher Stephen G; O'Neil Roger G; McConkey David J
Bax-mediated Ca2+ mobilization promotes cytochrome c release during apoptosis.
The Journal of biological chemistry 2002;277(23):20301-8.
-
2002: Ji Lin; Nishizaki Masahiko; Gao Boning; Burbee David; Kondo Masashi; Kamibayashi Craig; Xu Kai; Yen Nancy; Atkinson E Neely; Fang Bingliang; Lerman Michael I; Roth Jack A; Minna John D
Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo.
Cancer research 2002;62(9):2715-20.
-
2002: Nakamura Seiichi; Roth Jack A; Mukhopadhyay Tapas
Multiple lysine mutations in the C-terminus of p53 make it resistant to degradation mediated by MDM2 but not by human papillomavirus E6 and induce growth inhibition in MDM2-overexpressing cells.
Oncogene 2002;21(16):2605-10.
-
2002: Pataer Abujiang; Vorburger Stephan A; Barber Glen N; Chada Sunil; Mhashilkar Abner M; Zou-Yang Helena; Stewart Alexis L; Balachandran Siddharth; Roth Jack A; Hunt Kelly K; Swisher Stephen G
Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR).
Cancer research 2002;62(8):2239-43.
-
2002: Honda Tsuyoshi; Kagawa Shunsuke; Spurgers Kevin B; Gjertsen Bjorn T; Roth Jack A; Fang Bingliang; Lowe Stephanie L; Norris James S; Meyn Raymond E; McDonnell Timothy J
A recombinant adenovirus expressing wild-type Bax induces apoptosis in prostate cancer cells independently of their Bcl-2 status and androgen sensitivity.
Cancer biology & therapy 2002;1(2):163-7.
-
2002: Katsuda Koh; Kataoka Masafumi; Uno Futoshi; Murakami Takayoshi; Kondo Tadashi; Roth Jack A; Tanaka Noriaki; Fujiwara Toshiyoshi
Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells.
Oncogene 2002;21(13):2108-13.
-
2002: Nakamura Seiichi; Gomyo Yoshihito; Roth Jack A; Mukhopadhyay Tapas
C-terminus of p53 is required for G(2) arrest.
Oncogene 2002;21(13):2102-7.
-
2002: Swisher Stephen G; Roth Jack A; Carbone David P
Genetic and immunologic therapies for lung cancer.
Seminars in oncology 2002;29(1 Suppl 4):95-101.
-
2002: Vaporciyan Ara A; Merriman Kelly W; Ece Ferrah; Roth Jack A; Smythe W Roy; Swisher Stephen G; Walsh Garrett L; Nesbitt Jonathan C; Putnam Joseph B
Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation.
The Annals of thoracic surgery 2002;73(2):420-5; discussion 425-6.
-
2002: Gu J; Andreeff M; Roth J A; Fang B
hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
Gene therapy 2002;9(1):30-7.
-
2002: Swisher Stephen G; Wynn Paula; Putnam Joe B; Mosheim Melinda B; Correa Arlene M; Komaki Ritsuko R; Ajani Jaffer A; Smythe W Roy; Vaporciyan Ara A; Roth Jack A; Walsh Garrett L
Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy.
The Journal of thoracic and cardiovascular surgery 2002;123(1):175-83.
-
2001: Merritt J A; Roth J A; Logothetis C J
Clinical evaluation of adenoviral-mediated p53 gene transfer: review of INGN 201 studies.
Seminars in oncology 2001;28(5 Suppl 16):105-14.
-
2001: Honda T; Gjertsen B T; Spurgers K B; Briones F; Lee S J; Hobbs M L; Meyn R E; Roth J A; Logothetis C; McDonnell T J
Restoration of bax in prostate cancer suppresses tumor growth and augments therapeutic cell death induction.
Anticancer research 2001;21(5):3141-6.
-
2001: Nishizaki M; Meyn R E; Levy L B; Atkinson E N; White R A; Roth J A; Ji L
Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(9):2887-97.
-
2001: Roth J A; Grammer S F; Swisher S G; Komaki R; Nemunaitis J; Merritt J; Fujiwara T; Meyn R E
Gene therapy approaches for the management of non-small cell lung cancer.
Seminars in oncology 2001;28(4 Suppl 14):50-6.
-
2001: Fukazawa T; Fujiwara T; Uno F; Teraishi F; Kadowaki Y; Itoshima T; Takata Y; Kagawa S; Roth J A; Tschopp J; Tanaka N
Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells.
Oncogene 2001;20(37):5225-31.
-
2001: Ajani J A; Komaki R; Putnam J B; Walsh G; Nesbitt J; Pisters P W; Lynch P M; Vaporciyan A; Smythe R; Lahoti S; Raijman I; Swisher S; Martin F D; Roth J A
A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.
Cancer 2001;92(2):279-86.
-
2001: Kagawa S; Gu J; Honda T; McDonnell T J; Swisher S G; Roth J A; Fang B
Deficiency of caspase-3 in MCF7 cells blocks Bax-mediated nuclear fragmentation but not cell death.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(5):1474-80.
-
2001: Mhashilkar A M; Schrock R D; Hindi M; Liao J; Sieger K; Kourouma F; Zou-Yang X H; Onishi E; Takh O; Vedvick T S; Fanger G; Stewart L; Watson G J; Snary D; Fisher P B; Saeki T; Roth J A; Ramesh R; Chada S
Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy.
Molecular medicine (Cambridge, Mass.) 2001;7(4):271-82.
-
2001: Lippman S M; Lee J J; Karp D D; Vokes E E; Benner S E; Goodman G E; Khuri F R; Marks R; Winn R J; Fry W; Graziano S L; Gandara D R; Okawara G; Woodhouse C L; Williams B; Perez C; Kim H W; Lotan R; Roth J A; Hong W K
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.
Journal of the National Cancer Institute 2001;93(8):605-18.
-
2001: Lakka S S; Rajagopal R; Rajan M K; Mohan P M; Adachi Y; Dinh D H; Olivero W C; Gujrati M; Ali-Osman F; Roth J A; Yung W K; Kyritsis A P; Rao J S
Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):1087-93.
-
2001: Kagawa S; He C; Gu J; Koch P; Rha S J; Roth J A; Curley S A; Stephens L C; Fang B
Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.
Cancer research 2001;61(8):3330-8.
-
2001: Siegenthaler M P; Pisters K M; Merriman K W; Roth J A; Swisher S G; Walsh G L; Vaporciyan A A; Smythe W R; Putnam J B
Preoperative chemotherapy for lung cancer does not increase surgical morbidity.
The Annals of thoracic surgery 2001;71(4):1105-11; discussion 1111-2.
-
2001: Ramesh R; Saeki T; Templeton N S; Ji L; Stephens L C; Ito I; Wilson D R; Wu Z; Branch C D; Minna J D; Roth J A
Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(3):337-50.
-
2001: Koch P E; Guo Z S; Kagawa S; Gu J; Roth J A; Fang B
Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(3):278-83.
-
2001: Smythe W R; Estrera A L; Swisher S G; Merriman K W; Walsh G L; Putnam J B; Vaporciyan A A; Roth J A
Surgical resection of non-small cell carcinoma after treatment for small cell carcinoma.
The Annals of thoracic surgery 2001;71(3):962-6.
-
2001: Kawabe S; Munshi A; Zumstein L A; Wilson D R; Roth J A; Meyn R E
Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts.
International journal of radiation biology 2001;77(2):185-94.
-
2001: Schnirer I I; Komaki R; Yao J C; Swisher S; Putnam J; Pisters P W; Roth J A; Ajani J A
Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction.
American journal of clinical oncology 2001;24(1):91-5.
-
2001: Schumacher G; Bruckheimer E M; Beham A W; Honda T; Brisbay S; Roth J A; Logothetis C; McDonnell T J
Molecular determinants of cell death induction following adenovirus-mediated gene transfer of wild-type p53 in prostate cancer cells.
International journal of cancer. Journal international du cancer 2001;91(2):159-66.
-
2001: Pataer A; Smythe W R; Yu R; Fang B; McDonnell T; Roth J A; Swisher S G
Adenovirus-mediated Bak gene transfer induces apoptosis in mesothelioma cell lines.
The Journal of thoracic and cardiovascular surgery 2001;121(1):61-7.
-
2001: Walsh G L; Davis B M; Swisher S G; Vaporciyan A A; Smythe W R; Willis-Merriman K; Roth J A; Putnam J B
A single-institutional, multidisciplinary approach to primary sarcomas involving the chest wall requiring full-thickness resections.
The Journal of thoracic and cardiovascular surgery 2001;121(1):48-60.
-
2001: Roth J A; Grammer S F; Swisher S G; Komaki R; Nemunaitis J; Merritt J; Meyn R E
P53 gene replacement for cancer--interactions with DNA damaging agents.
Acta oncologica (Stockholm, Sweden) 2001;40(6):739-44.
-
2000: Saeki T; Mhashilkar A; Chada S; Branch C; Roth J A; Ramesh R
Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro.
Gene therapy 2000;7(23):2051-7.
-
2000: Nakamura S; Roth J A; Mukhopadhyay T
Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination.
Molecular and cellular biology 2000;20(24):9391-8.
-
2000: Cowen D; Salem N; Ashoori F; Meyn R; Meistrich M L; Roth J A; Pollack A
Prostate cancer radiosensitization in vivo with adenovirus-mediated p53 gene therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(11):4402-8.
-
2000: Kawabe S; Roth J A; Wilson D R; Meyn R E
Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner.
Oncogene 2000;19(47):5359-66.
-
2000: Waku T; Fujiwara T; Shao J; Itoshima T; Murakami T; Kataoka M; Gomi S; Roth J A; Tanaka N
Contribution of CD95 ligand-induced neutrophil infiltration to the bystander effect in p53 gene therapy for human cancer.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(10):5884-90.
-
2000: Roth J A; Grammer S F; Swisher S G; Nemunaitis J; Merritt J; Meyn R E
Gene replacement strategies for treating non-small cell lung cancer.
Seminars in radiation oncology 2000;10(4):333-42.
-
2000: Gu J; Kagawa S; Takakura M; Kyo S; Inoue M; Roth J A; Fang B
Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
Cancer research 2000;60(19):5359-64.
-
2000: Sueoka N; Lee H Y; Wiehle S; Cristiano R J; Fang B; Ji L; Roth J A; Hong W K; Cohen P; Kurie J M
Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells.
Oncogene 2000;19(38):4432-6.
-
2000: Komaki R; Roth J A; Walsh G L; Putnam J B; Vaporciyan A; Lee J S; Fossella F V; Chasen M; Delclos M E; Cox J D
Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center.
International journal of radiation oncology, biology, physics 2000;48(2):347-54.
-
2000: Sueoka N; Lee H Y; Walsh G L; Fang B; Ji L; Roth J A; LaPushin R; Hong W K; Cohen P; Kurie J M
Insulin-like growth factor binding protein-6 inhibits the growth of human bronchial epithelial cells and increases in abundance with all-trans-retinoic acid treatment.
American journal of respiratory cell and molecular biology 2000;23(3):297-303.
-
2000: Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough W G; Liu T J; Roth J A; Tanaka N; Kodama M
Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2851-9.
-
2000: Swisher S G; Deford L; Merriman K W; Walsh G L; Smythe R; Vaporicyan A; Ajani J A; Brown T; Komaki R; Roth J A; Putnam J B
Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer.
The Journal of thoracic and cardiovascular surgery 2000;119(6):1126-32.
-
2000: Yen N; Ioannides C G; Xu K; Swisher S G; Lawrence D D; Kemp B L; El-Naggar A K; Cristiano R J; Fang B; Glisson B S; Hong W K; Khuri F R; Kurie J M; Lee J J; Lee J S; Merritt J A; Mukhopadhyay T; Nesbitt J C; Nguyen D; Perez-Soler R; Pisters K M; Putnam J B; Schrump D S; Shin D M; Walsh G L; Roth J A
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53).
Cancer gene therapy 2000;7(4):530-6.
-
2000: Pearson A S; Spitz F R; Swisher S G; Kataoka M; Sarkiss M G; Meyn R E; McDonnell T J; Cristiano R J; Roth J A
Up-regulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):887-90.
-
2000: Kataoka M; Wiehle S; Spitz F; Schumacher G; Roth J A; Cristiano R J
Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells.
Oncogene 2000;19(12):1589-95.
-
2000: Kagawa S; Gu J; Swisher S G; Ji L; Roth J A; Lai D; Stephens L C; Fang B
Antitumor effect of adenovirus-mediated Bax gene transfer on p53-sensitive and p53-resistant cancer lines.
Cancer research 2000;60(5):1157-61.
-
2000: Toloza E M; Roth J A; Swisher S G
Molecular events in bronchogenic carcinoma and their implications for therapy.
Seminars in surgical oncology 2000;18(2):91-9.
-
2000: Putnam J B; Walsh G L; Swisher S G; Roth J A; Suell D M; Vaporciyan A A; Smythe W R; Merriman K W; DeFord L L
Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter.
The Annals of thoracic surgery 2000;69(2):369-75.
-
2000: Pataer A; Fang B; Yu R; Kagawa S; Hunt K K; McDonnell T J; Roth J A; Swisher S G
Adenoviral Bak overexpression mediates caspase-dependent tumor killing.
Cancer research 2000;60(4):788-92.
-
2000: Shao J; Fujiwara T; Kadowaki Y; Fukazawa T; Waku T; Itoshima T; Yamatsuji T; Nishizaki M; Roth J A; Tanaka N
Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells.
Oncogene 2000;19(6):726-36.
-
2000: Swisher S G; Roth J A
Gene therapy in lung cancer.
Current oncology reports 2000;2(1):64-70.
-
2000: Kagawa S; Pearson S A; Ji L; Xu K; McDonnell T J; Swisher S G; Roth J A; Fang B
A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax.
Gene therapy 2000;7(1):75-9.
-
1999: Kadowaki Y; Fujiwara T; Fukazawa T; Shao J; Yasuda T; Itoshima T; Kagawa S; Hudson L G; Roth J A; Tanaka N
Induction of differentiation-dependent apoptosis in human esophageal squamous cell carcinoma by adenovirus-mediated p21sdi1 gene transfer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4233-41.
-
1999: Pearson A S; Koch P E; Atkinson N; Xiong M; Finberg R W; Roth J A; Fang B
Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4208-13.
-
1999: Gandhi S; Walsh G L; Komaki R; Gokaslan Z L; Nesbitt J C; Putnam J B; Roth J A; Merriman K W; McCutcheon I E; Munden R F; Swisher S G
A multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion.
The Annals of thoracic surgery 1999;68(5):1778-84; discussion 1784-5.
-
1999: Wolf J K; Mills G B; Bazzet L; Bast R C; Roth J A; Gershenson D M
Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 status.
Gynecologic oncology 1999;75(2):261-6.
-
1999: Roth J A; Swisher S G; Meyn R E
p53 tumor suppressor gene therapy for cancer.
Oncology (Williston Park, N.Y.) 1999;13(10 Suppl 5):148-54.
-
1999: Mohan P M; Chintala S K; Mohanam S; Gladson C L; Kim E S; Gokaslan Z L; Lakka S S; Roth J A; Fang B; Sawaya R; Kyritsis A P; Rao J S
Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth.
Cancer research 1999;59(14):3369-73.
-
1999: Ji L; Fang B; Yen N; Fong K; Minna J D; Roth J A
Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
Cancer research 1999;59(14):3333-9.
-
1999: Beaupre D M; Talpaz M; Marini F C; Cristiano R J; Roth J A; Estrov Z; Albitar M; Freedman M H; Kurzrock R
Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RAS.
Cancer research 1999;59(12):2971-80.
-
1999: Ji L; Fang B; Roth J A
A rapid, sensitive, and nonradioactive method for assay of FHIT Ap3A hydrolase activity by fluorescence thin-layer chromatographic image analysis.
Analytical biochemistry 1999;271(1):114-6.
-
1999: Nishizaki M; Fujiwara T; Tanida T; Hizuta A; Nishimori H; Tokino T; Nakamura Y; Bouvet M; Roth J A; Tanaka N
Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(5):1015-23.
-
1999: Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub L B; Roth J A; Tanaka N
Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Oncogene 1999;18(13):2189-99.
-
1999: Ji L; Bouvet M; Price R E; Roth J A; Fang B
Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
Gene therapy 1999;6(3):393-402.
-
1998: Kataoka M; Schumacher G; Cristiano R J; Atkinson E N; Roth J A; Mukhopadhyay T
An agent that increases tumor suppressor transgene product coupled with systemic transgene delivery inhibits growth of metastatic lung cancer in vivo.
Cancer research 1998;58(21):4761-5.
-
1998: Pearson A S; Bouvet M; Evans D B; Roth J A
Gene therapy and pancreatic cancer.
Frontiers in bioscience : a journal and virtual library 1998;3():E230-7.
-
1998: Fang B; Xu B; Koch P; Roth J A
Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells.
Gene therapy 1998;5(10):1420-4.
-
1998: Roth J A
Restoration of tumour suppressor gene expression for cancer.
Forum (Genoa, Italy) 1998;8(4):368-76.
-
1998: Xu B; Wiehle S; Roth J A; Cristiano R J
The contribution of poly-L-lysine, epidermal growth factor and streptavidin to EGF/PLL/DNA polyplex formation.
Gene therapy 1998;5(9):1235-43.
-
1998: Mukhopadhyay T; Multani A S; Roth J A; Pathak S
Reduced telomeric signals and increased telomeric associations in human lung cancer cell lines undergoing p53-mediated apoptosis.
Oncogene 1998;17(7):901-6.
-
1998: Roth J A; Atkinson E N; Fossella F; Komaki R; Bernadette Ryan M; Putnam J B; Lee J S; Dhingra H; De Caro L; Chasen M; Hong W K
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1998;21(1):1-6.
-
1998: Mukhopadhyay T; Roth J A
Superinduction of wild-type p53 protein after 2-methoxyestradiol treatment of Ad5p53-transduced cells induces tumor cell apoptosis.
Oncogene 1998;17(2):241-6.
-
1998: Shin D M; Walsh G L; Komaki R; Putnam J B; Nesbitt J; Ro J Y; Shin H J; Ki K H; Wimberly A; Pisters K M; Schrump D; Gregurich M A; Cox J D; Roth J A; Hong W K
A multidisciplinary approach to therapy for unresectable malignant thymoma.
Annals of internal medicine 1998;129(2):100-4.
-
1998: Swisher S G; Roth J A
Gene therapy for human lung cancers.
Surgical oncology clinics of North America 1998;7(3):603-16.
-
1998: Roth J A; Swisher S G; Merritt J A; Lawrence D D; Kemp B L; Carrasco C H; El-Naggar A K; Fossella F V; Glisson B S; Hong W K; Khurl F R; Kurie J M; Nesbitt J C; Pisters K; Putnam J B; Schrump D S; Shin D M; Walsh G L
Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.
Seminars in oncology 1998;25(3 Suppl 8):33-7.
-
1998: Clayman G L; el-Naggar A K; Lippman S M; Henderson Y C; Frederick M; Merritt J A; Zumstein L A; Timmons T M; Liu T J; Ginsberg L; Roth J A; Hong W K; Bruso P; Goepfert H
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2221-32.
-
1998: Bouvet M; Ellis L M; Nishizaki M; Fujiwara T; Liu W; Bucana C D; Fang B; Lee J J; Roth J A
Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer.
Cancer research 1998;58(11):2288-92.
-
1998: Bouvet M; Fang B; Ekmekcioglu S; Ji L; Bucana C D; Hamada K; Grimm E A; Roth J A
Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide.
Gene therapy 1998;5(2):189-95.
-
1998: Fang B; Ji L; Bouvet M; Roth J A
Evaluation of GAL4/TATA in vivo. Induction of transgene expression by adenovirally mediated gene codelivery.
The Journal of biological chemistry 1998;273(9):4972-5.
-
1998: Fang X; Jin X; Xu H J; Liu L; Peng H Q; Hogg D; Roth J A; Yu Y; Xu F; Bast R C; Mills G B
Expression of p16 induces transcriptional downregulation of the RB gene.
Oncogene 1998;16(1):1-8.
-
1998: Cristiano R J; Xu B; Nguyen D; Schumacher G; Kataoka M; Spitz F R; Roth J A
Viral and nonviral gene delivery vectors for cancer gene therapy.
Cancer detection and prevention 1998;22(5):445-54.
-
1998: Mukhopadhyay T; Roth J A
Isolation of total RNA from tissues or cell lines. Visualization in gel.
Methods in molecular biology (Clifton, N.J.) 1998;86():55-9.
-
1997: Walsh G L; Gokaslan Z L; McCutcheon I E; Mineo M T; Yasko A W; Swisher S G; Schrump D S; Nesbitt J C; Putnam J B; Roth J A
Anterior approaches to the thoracic spine in patients with cancer: indications and results.
The Annals of thoracic surgery 1997;64(6):1611-8.
-
1997: Fang B; Koch P; Bouvet M; Ji L; Roth J A
A packaging system for SV40 vectors without viral coding sequences.
Analytical biochemistry 1997;254(1):139-43.
-
1997: Ogawa N; Fujiwara T; Kagawa S; Nishizaki M; Morimoto Y; Tanida T; Hizuta A; Yasuda T; Roth J A; Tanaka N
Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent.
International journal of cancer. Journal international du cancer 1997;73(3):367-70.
-
1997: Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang W W; Roth J A; Tanaka N
p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
Oncogene 1997;15(16):1903-9.
-
1997: Nguyen D M; Wiehle S A; Koch P E; Branch C; Yen N; Roth J A; Cristiano R J
Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.
Cancer gene therapy 1997;4(3):191-8.
-
1997: Nguyen D M; Wiehle S A; Roth J A; Cristiano R J
Gene delivery into malignant cells in vivo by a conjugated adenovirus/DNA complex.
Cancer gene therapy 1997;4(3):183-90.
-
1997: Ferson D Z; Nesbitt J C; Nesbitt K; Walsh G L; Putnam J B; Schrump D S; Johansen M J; Jones R L; Roth J A
The laryngeal mask airway: a new standard for airway evaluation in thoracic surgery.
The Annals of thoracic surgery 1997;63(3):768-72.
-
1997: Overholt S M; Liu T J; Taylor D L; Wang M; El-Naggar A K; Shillitoe E; Adler-Storthz K; John L S; Zhang W W; Roth J A; Clayman G L
Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(2):185-91.
-
1997: Mukhopadhyay T; Roth J A
Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol.
Oncogene 1997;14(3):379-84.
-
1997: Roth J A; Cristiano R J
Gene therapy for cancer: what have we done and where are we going?
Journal of the National Cancer Institute 1997;89(1):21-39.
-
1996: Horio Y; Chen A; Rice P; Roth J A; Malkinson A M; Schrump D S
Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice.
Molecular carcinogenesis 1996;17(4):217-23.
-
1996: Spitz F R; Nguyen D; Skibber J M; Cusack J; Roth J A; Cristiano R J
In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer.
Anticancer research 1996;16(6B):3415-22.
-
1996: Schrump D S; Chen G A; Consuli U; Jin X; Roth J A
Inhibition of esophageal cancer proliferation by adenovirally mediated delivery of p16INK4.
Cancer gene therapy 1996;3(6):357-64.
-
1996: Nguyen D M; Spitz F R; Yen N; Cristiano R J; Roth J A
Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer.
The Journal of thoracic and cardiovascular surgery 1996;112(5):1372-6; discussion 1376-7.
-
1996: Hamada K; Sakaue M; Alemany R; Zhang W W; Horio Y; Roth J A; Mitchell M F
Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells.
Gynecologic oncology 1996;63(2):219-27.
-
1996: Spitz F R; Nguyen D; Skibber J M; Meyn R E; Cristiano R J; Roth J A
Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(10):1665-71.
-
1996: Eicher S A; Clayman G L; Liu T J; Shillitoe E J; Storthz K A; Roth J A; Lotan R
Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(10):1659-64.
-
1996: Alemany R; Ruan S; Kataoka M; Koch P E; Mukhopadhyay T; Cristiano R J; Roth J A; Zhang W W
Growth inhibitory effect of anti-K-ras adenovirus on lung cancer cells.
Cancer gene therapy 1996;3(5):296-301.
-
1996: Roth J A; Nguyen D; Lawrence D D; Kemp B L; Carrasco C H; Ferson D Z; Hong W K; Komaki R; Lee J J; Nesbitt J C; Pisters K M; Putnam J B; Schea R; Shin D M; Walsh G L; Dolormente M M; Han C I; Martin F D; Yen N; Xu K; Stephens L C; McDonnell T J; Mukhopadhyay T; Cai D
Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.
Nature medicine 1996;2(9):985-91.
-
1996: Cusack J C; Spitz F R; Nguyen D; Zhang W W; Cristiano R J; Roth J A
High levels of gene transduction in human lung tumors following intralesional injection of recombinant adenovirus.
Cancer gene therapy 1996;3(4):245-9.
-
1996: Mukhopadhyay T; Roth J A
Functional inactivation of p53 by antisense RNA induces invasive ability of lung carcinoma cells and downregulates cytokeratin synthesis.
Anticancer research 1996;16(4A):1683-9.
-
1996: Hamada K; Alemany R; Zhang W W; Hittelman W N; Lotan R; Roth J A; Mitchell M F
Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer.
Cancer research 1996;56(13):3047-54.
-
1996: Roth J A
Modification of mutant K-ras gene expression in non-small cell lung cancer (NSCLC).
Human gene therapy 1996;7(7):875-89.
-
1996: Roth J A
Modification of tumor suppressor gene expression in non-small cell lung cancer (NSCLC) with a retroviral vector expressing wildtype (normal) p53.
Human gene therapy 1996;7(7):861-74.
-
1996: Roth J A
Modification of tumor suppressor gene expression and induction of apoptosis in non-small cell lung cancer (NSCLC) with an adenovirus vector expressing wildtype p53 and cisplatin.
Human gene therapy 1996;7(8):1013-30.
-
1996: Hamada K; Zhang W W; Alemany R; Wolf J; Roth J A; Mitchell M F
Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro.
Gynecologic oncology 1996;60(3):373-9.
-
1996: Gomez-Manzano C; Fueyo J; Kyritsis A P; Steck P A; Roth J A; McDonnell T J; Steck K D; Levin V A; Yung W K
Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis.
Cancer research 1996;56(4):694-9.
-
1996: Cristiano R J; Roth J A
Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor.
Cancer gene therapy 1996;3(1):4-10.
-
1996: Mukhopadhyay T; Roth J A
p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines.
Anticancer research 1996;16(1):105-12.
-
1996: Mukhopadhyay T; Roth J A
Antisense regulation of oncogenes in human cancer.
Critical reviews in oncogenesis 1996;7(3-4):151-90.
-
1995: Walsh G L; O'Connor M; Willis K M; Milas M; Wong R S; Nesbitt J C; Putnam J B; Lee J J; Roth J A
Is follow-up of lung cancer patients after resection medically indicated and cost-effective?
The Annals of thoracic surgery 1995;60(6):1563-70; discussion 1570-2.
-
1995: Mukhopadhyay T; Roth J A
Antisense therapy for cancer.
The cancer journal from Scientific American 1995;1(4):233-42.
-
1995: Soysal O; Walsh G L; Nesbitt J C; McMurtrey M J; Roth J A; Putnam J B
Resection of sternal tumors: extent, reconstruction, and survival.
The Annals of thoracic surgery 1995;60(5):1353-8; discussion 1358-9.
-
1995: Cai D W; Mukhopadhyay T; Roth J A
Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA.
Cancer gene therapy 1995;2(3):199-205.
-
1995: Mukhopadhyay T; Roth J A; Maxwell S A
Altered expression of the p50 subunit of the NF-kappa B transcription factor complex in non-small cell lung carcinoma.
Oncogene 1995;11(5):999-1003.
-
1995: Gingras M C; Roussel E; Roth J A; Moser R P
Little expression of cytokine mRNA by fresh tumour-infiltrating mononuclear leukocytes from glioma and lung adenocarcinoma.
Cytokine 1995;7(6):580-8.
-
1995: Nesbitt J C; Putnam J B; Walsh G L; Roth J A; Mountain C F
Survival in early-stage non-small cell lung cancer.
The Annals of thoracic surgery 1995;60(2):466-72.
-
1995: Jin X; Nguyen D; Zhang W W; Kyritsis A P; Roth J A
Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector.
Cancer research 1995;55(15):3250-3.
-
1995: Putnam J B; Roth J A
Surgical treatment for pulmonary metastases from sarcoma.
Hematology/oncology clinics of North America 1995;9(4):869-87.
-
1995: Roussel E; Gingras M C; Grimm E A; Roth J A
High expression of adhesion molecules/activation markers with little interleukin-2, interferon gamma, and tumor necrosis factor beta gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma.
Cancer immunology, immunotherapy : CII 1995;41(1):1-9.
-
1995: Roth J A
Molecular events in lung cancer.
Lung cancer (Amsterdam, Netherlands) 1995;12 Suppl 2():S3-15.
-
1995: Owen-Schaub L B; Zhang W; Cusack J C; Angelo L S; Santee S M; Fujiwara T; Roth J A; Deisseroth A B; Zhang W W; Kruzel E
Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression.
Molecular and cellular biology 1995;15(6):3032-40.
-
1995: Zhang W W; Koch P E; Roth J A
Detection of wild-type contamination in a recombinant adenoviral preparation by PCR.
BioTechniques 1995;18(3):444-7.
-
1995: Roth J A
Multimodality treatment of cancer arising from Barrett's epithelium.
World journal of surgery 1995;19(2):205-9.
-
1995: Wang J; Bucana C D; Roth J A; Zhang W W
Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53.
Cancer gene therapy 1995;2(1):9-17.
-
1995: Komaki R; Shin D M; Glisson B S; Fossella F V; Murphy W K; Garden A S; Oswald M J; Hong W K; Roth J A; Peters L J
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
International journal of radiation oncology, biology, physics 1995;31(4):807-11.
-
1995: Roth J A
The training and preservation of thoracic surgeon scientists.
Chest surgery clinics of North America 1995;5(1):7-16.
-
1995: Zhang W W; Alemany R; Wang J; Koch P E; Ordonez N G; Roth J A
Safety evaluation of Ad5CMV-p53 in vitro and in vivo.
Human gene therapy 1995;6(2):155-64.
-
1995: Ding Z M; Cristiano R J; Roth J A; Takacs B; Kuo M T
Malarial circumsporozoite protein is a novel gene delivery vehicle to primary hepatocyte cultures and cultured cells.
The Journal of biological chemistry 1995;270(8):3667-76.
-
1995: Kim Y H; Ajani J A; Ota D M; Lynch P; Roth J A
Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach.
Cancer 1995;75(2):451-6.
-
1995: Clayman G L; el-Naggar A K; Roth J A; Zhang W W; Goepfert H; Taylor D L; Liu T J
In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.
Cancer research 1995;55(1):1-6.
-
1995: Ajani J A; Roth J A; Putnam J B; Walsh G; Lynch P M; Roubein L D; Ryan M B; Natrajan G; Gould P
Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction.
European journal of cancer (Oxford, England : 1990) 1995;31A(5):665-70.
-
1994: Zhang W W; Roth J A
Anti-oncogene and tumor suppressor gene therapy--examples from a lung cancer animal model.
In vivo (Athens, Greece) 1994;8(5):755-69.
-
1994: Roth J A
Surgical approaches to locally advanced potentially resectable non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1994;11 Suppl 3():S25-30.
-
1994: Fujiwara T; Cai D W; Georges R N; Mukhopadhyay T; Grimm E A; Roth J A
Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model.
Journal of the National Cancer Institute 1994;86(19):1458-62.
-
1994: Mukhopadhyay T; Roth J A
Visualization of RNA in gel by shortwave UV epi-illumination without staining.
BioTechniques 1994;17(4):619-20.
-
1994: Walsh G L; Morice R C; Putnam J B; Nesbitt J C; McMurtrey M J; Ryan M B; Reising J M; Willis K M; Morton J D; Roth J A
Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption.
The Annals of thoracic surgery 1994;58(3):704-10; discussion 711.
-
1994: Roth J A; Putnam J B
Surgery for cancer of the esophagus.
Seminars in oncology 1994;21(4):453-61.
-
1994: Liu T J; Zhang W W; Taylor D L; Roth J A; Goepfert H; Clayman G L
Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.
Cancer research 1994;54(14):3662-7.
-
1994: Roussel E; Gingras M C; Ro J Y; Branch C; Roth J A
Loss of alpha 1 beta 1 and reduced expression of other beta 1 integrins and CAM in lung adenocarcinoma compared with pneumocytes.
Journal of surgical oncology 1994;56(3):198-208.
-
1994: Fujiwara T; Grimm E A; Mukhopadhyay T; Zhang W W; Owen-Schaub L B; Roth J A
Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene.
Cancer research 1994;54(9):2287-91.
-
1994: Roth J A; Fossella F; Komaki R; Ryan M B; Putnam J B; Lee J S; Dhingra H; De Caro L; Chasen M; McGavran M
A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.
Journal of the National Cancer Institute 1994;86(9):673-80.
-
1994: Roth J A
The cell and molecular biology of esophageal carcinoma.
Chest surgery clinics of North America 1994;4(2):205-16.
-
1994: Fujiwara T; Mukhopadhyay T; Cai D W; Morris D K; Roth J A; Grimm E A
Retroviral-mediated transduction of p53 gene increases TGF-beta expression in a human glioblastoma cell line.
International journal of cancer. Journal international du cancer 1994;56(6):834-9.
-
1994: Zhang W W; Fang X; Mazur W; French B A; Georges R N; Roth J A
High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.
Cancer gene therapy 1994;1(1):5-13.
-
1994: Putnam J B; Suell D M; McMurtrey M J; Ryan M B; Walsh G L; Natarajan G; Roth J A
Comparison of three techniques of esophagectomy within a residency training program.
The Annals of thoracic surgery 1994;57(2):319-25.
-
1994: Roth J A; Hölscher A H; Schneider P M
[Markers of malignant potential and clinical management of dysplasia in Barrett esophagus]
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 1994;65(2):96-101.
-
1994: Shin D M; Kim J; Ro J Y; Hittelman J; Roth J A; Hong W K; Hittelman W N
Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis.
Cancer research 1994;54(2):321-6.
-
1994: Roth J A
Modulation of oncogene and tumor-suppressor gene expression: a novel strategy for cancer prevention and treatment.
Annals of surgical oncology 1994;1(1):79-86.
-
1994: Maxwell S A; Roth J A
Posttranslational regulation of p53 tumor suppressor protein function.
Critical reviews in oncogenesis 1994;5(1):23-57.
-
1994: Roth J A; Mukhopadhyay T; Zhang W W; Fujiwara T; Georges R
Gene replacement strategies for the prevention and therapy of cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(13):2032-7.
-
1993: Maxwell S A; Roth J A
Binding of cellular proteins to a conformational domain of tumor suppressor protein p53.
Oncogene 1993;8(12):3421-6.
-
1993: Zhang W W; Fang X; Branch C D; Mazur W; French B A; Roth J A
Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis.
BioTechniques 1993;15(5):868-72.
-
1993: Srinivasan R; Roth J A; Maxwell S A
Sequence-specific interaction of a conformational domain of p53 with DNA.
Cancer research 1993;53(22):5361-4.
-
1993: Cai D W; Mukhopadhyay T; Liu Y; Fujiwara T; Roth J A
Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer.
Human gene therapy 1993;4(5):617-24.
-
1993: Fujiwara T; Grimm E A; Mukhopadhyay T; Cai D W; Owen-Schaub L B; Roth J A
A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis.
Cancer research 1993;53(18):4129-33.
-
1993: Mukhopadhyay T; Roth J A
A codon 248 p53 mutation retains tumor suppressor function as shown by enhancement of tumor growth by antisense p53.
Cancer research 1993;53(18):4362-6.
-
1993: Zhang Y; Mukhopadhyay T; Donehower L A; Georges R N; Roth J A
Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype.
Human gene therapy 1993;4(4):451-60.
-
1993: Roth J A
Targeting lung cancer genes: a novel approach to cancer prevention and therapy.
Seminars in thoracic and cardiovascular surgery 1993;5(3):178-83.
-
1993: Putnam J B; Suell D M; Natarajan G; Roth J A
Extended resection of pulmonary metastases: is the risk justified?
The Annals of thoracic surgery 1993;55(6):1440-6.
-
1993: Georges R N; Mukhopadhyay T; Zhang Y; Yen N; Roth J A
Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct.
Cancer research 1993;53(8):1743-6.
-
1993: Chung K Y; Mukhopadhyay T; Kim J; Casson A; Ro J Y; Goepfert H; Hong W K; Roth J A
Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Cancer research 1993;53(7):1676-83.
-
1993: Ajani J A; Roth J A; Ryan M B; Putnam J B; Pazdur R; Levin B; Gutterman J U; McMurtrey M
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(1):22-8.
-
1992: Roth J A
Molecular surgery for cancer.
Archives of surgery (Chicago, Ill. : 1960) 1992;127(11):1298-302.
-
1992: Lazenby A W; Roth J A; Owen-Schaub L B; Grimm E A
IL-1 synergy with IL-2 in the generation of lymphokine activated killer cells is mediated by TNF-alpha and beta (lymphotoxin).
Cytokine 1992;4(6):479-87.
-
1992: Roth J A
[Squamous cell cancer of the esophagus. Treatment concept at the Houston M.D. Anderson Cancer Center]
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 1992;63(9):683-8.
-
1992: Cybulsky I J; Lanza L A; Ryan M B; Putnam J B; McMurtrey M M; Roth J A
Prognostic significance of computed tomography in resected N2 lung cancer.
The Annals of thoracic surgery 1992;54(3):533-7.
-
1992: Lanza L A; Natarajan G; Roth J A; Putnam J B
Long-term survival after resection of pulmonary metastases from carcinoma of the breast.
The Annals of thoracic surgery 1992;54(2):244-7; discussion 248.
-
1992: Roth J A
New approaches to treating early lung cancer.
Cancer research 1992;52(9 Suppl):2652s-2657s.
-
1992: Morice R C; Peters E J; Ryan M B; Putnam J B; Ali M K; Roth J A
Exercise testing in the evaluation of patients at high risk for complications from lung resection.
Chest 1992;101(2):356-61.
-
1992: Casson A G; Putnam J B; Natarajan G; Johnston D A; Mountain C; McMurtrey M; Roth J A
Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma.
Cancer 1992;69(3):662-8.
-
1992: Putnam E A; Yen N; Gallick G E; Steck P A; Fang K; Akpakip B; Gazdar A F; Roth J A
Autocrine growth stimulation by transforming growth factor-alpha in human non-small cell lung cancer.
Surgical oncology 1992;1(1):49-60.
-
1992: Ajani J A; Ryan B; Rich T A; McMurtrey M; Roth J A; DeCaro L; Levin B; Mountain C
Prolonged chemotherapy for localised squamous carcinoma of the oesophagus.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):880-4.
-
1991: Casson A G; Mukhopadhyay T; Cleary K R; Ro J Y; Levin B; Roth J A
Oncogene activation in esophageal cancer.
The Journal of thoracic and cardiovascular surgery 1991;102(5):707-9.
-
1991: Yang S C; Fry K D; Grimm E A; Roth J A
Phenotype and cytolytic activity of mouse tumor-bearer splenocytes and tumor-infiltrating lymphocytes from K-1735 melanoma metastases following anti-CD3, interleukin-2, and tumor necrosis factor-alpha combination immunotherapy.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1991;10(5):326-35.
-
1991: Zatopek N K; Holoye P Y; Ellerbroek N A; Hong W K; Roth J A; Ryan M B; Komaki R; Pang A C; Glisson B S
Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb).
American journal of clinical oncology 1991;14(5):427-32.
-
1991: Casson A G; Mukhopadhyay T; Cleary K R; Ro J Y; Levin B; Roth J A
p53 gene mutations in Barrett's epithelium and esophageal cancer.
Cancer research 1991;51(16):4495-9.
-
1991: Gorenstein L A; Putnam J B; Natarajan G; Balch C A; Roth J A
Improved survival after resection of pulmonary metastases from malignant melanoma.
The Annals of thoracic surgery 1991;52(2):204-10.
-
1991: Yang S C; Grimm E A; Parkinson D R; Carinhas J; Fry K D; Mendiguren-Rodriguez A; Licciardello J; Owen-Schaub L B; Hong W K; Roth J A
Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.
Cancer research 1991;51(14):3669-76.
-
1991: Casson A G; Putnam J B; Natarajan G; Johnston D A; Mountain C; McMurtrey M; Roth J A
Efficacy of pulmonary metastasectomy for recurrent soft tissue sarcoma.
Journal of surgical oncology 1991;47(1):1-4.
-
1991: Slater J D; Ellerbroek N A; Barkley H T; Mountain C; Oswald M J; Roth J A; Peters L J
Radiation therapy following resection of non-small cell bronchogenic carcinoma.
International journal of radiation oncology, biology, physics 1991;20(5):945-51.
-
1991: Mukhopadhyay T; Tainsky M; Cavender A C; Roth J A
Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA.
Cancer research 1991;51(6):1744-8.
-
1991: Lanza L A; Putnam J B; Benjamin R S; Roth J A
Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases.
The Annals of thoracic surgery 1991;51(2):219-24.
-
1991: Ellerbroek N A; Fossella F V; Rich T A; Ajani J A; Komaki R; Roth J A; Holoye P Y
Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma.
International journal of radiation oncology, biology, physics 1991;20(2):351-5.
-
1990: Ajani J A; Roth J A; Ryan B; McMurtrey M; Rich T A; Jackson D E; Abbruzzese J L; Levin B; DeCaro L; Mountain C
Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(7):1231-8.
-
1990: Putnam J B; Lammermeier D E; Colon R; McMurtrey M J; Ali M K; Roth J A
Predicted pulmonary function and survival after pneumonectomy for primary lung carcinoma.
The Annals of thoracic surgery 1990;49(6):909-14; discussion 915.
-
1990: Yang S C; Owen-Schaub L B; Roth J A; Grimm E A
Characterization of OKT3-initiated lymphokine-activated effectors expanded with interleukin 2 and tumor necrosis factor alpha.
Cancer research 1990;50(12):3526-32.
-
1990: Yang S C; Fry K D; Grimm E A; Roth J A
Successful combination immunotherapy for the generation in vivo of antitumor activity with anti-CD3, interleukin 2, and tumor necrosis factor alpha.
Archives of surgery (Chicago, Ill. : 1960) 1990;125(2):220-5.
-
1990: Yang S C; Owen-Schaub L; Mendiguren-Rodriguez A; Grimm E A; Hong W K; Roth J A
Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha.
The Journal of thoracic and cardiovascular surgery 1990;99(1):8-12; discussion 12-3.
-
1989: Roth J A; Thomsen S; Fry K D; Scannon P; Chang C
Analysis of gp74 expression by transformed rat fibroblasts from experimental pulmonary metastases following specific ricin A-chain immunotoxin therapy.
Cancer research 1989;49(20):5708-12.
-
1989: Ryan M B; McMurtrey M J; Roth J A
Current management of chest-wall tumors.
The Surgical clinics of North America 1989;69(5):1061-80.
-
1989: Schneider P M; Hung M C; Chiocca S M; Manning J; Zhao X Y; Fang K; Roth J A
Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.
Cancer research 1989;49(18):4968-71.
-
1989: Wahi R; McMurtrey M J; DeCaro L F; Mountain C F; Ali M K; Smith T L; Roth J A
Determinants of perioperative morbidity and mortality after pneumonectomy.
The Annals of thoracic surgery 1989;48(1):33-7.
-
1989: Ames R S; North S M; Fry K D; Tainsky M A; Nicolson G L; Roth J A
Analysis of expression of cell surface antigen Mr 74,000 phosphoglycoprotein in normal, oncogene-transformed, and neoplastic rat cell lines.
Cancer research 1989;49(9):2312-9.
-
1989: Yang S C; Owen-Schaub L; Grimm E A; Roth J A
Induction of lymphokine-activated killer cytotoxicity with interleukin-2 and tumor necrosis factor-alpha against primary lung cancer targets.
Cancer immunology, immunotherapy : CII 1989;29(3):193-8.
-
1988: Roth J A; Ames R S; Fry K; Lee H M; Scannon P J
Mediation of reduction of spontaneous and experimental pulmonary metastases by ricin A-chain immunotoxin 45-2D9-RTA with potentiation by systemic monensin in mice.
Cancer research 1988;48(12):3496-501.
-
1986: Roth J A; Ames R S; Byers V; Lee H M; Scannon P J
Monoclonal antibody 45-2D9 conjugated to the A chain of ricin is specifically toxic to c-Ha-ras-transfected NIH 3T3 cells expressing gp74.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(6):2305-10.
Sign-in to see more